ALC Alcon Inc.

73.91USD62.28 CHF · SWX-1.64%Mkt Cap: 35.51B USDP/E: 57.14

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics…

Institutional holders20 on file

Key Statistics

Company
Market Cap35.51B USD
Enterprise Value39.70B USD
Revenue (TTM)10.98B USD
Gross Profit5.75B USD
Net Income (TTM)980.00M USD
Revenue/Share22.60 USD
Last Price73.91 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees25.0K
CountryCH
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINCH0432492467
Valuation
P/E (Trailing)57.14
P/E (Forward)17.27
PEG1.38
EV/EBITDA13.98
EV/Revenue3.61
P/S2.72
P/B1.67
EPS (TTM)1.09 USD
EPS (Forward)3.61 USD
52W Range
56.7370% of range81.10
52W High81.10 USD
52W Low56.73 USD
Profitability
Gross Margin55.24%
Oper. Margin12.93%
EBITDA Margin21.78%
Profit Margin9.42%
ROE4.45%
ROA3.11%
ROIC4.48%
ROCE4.77%
Growth
Revenue Growth4.70%
Earnings Growth12.50%
Cash Flow & Leverage
Operating CF2.27B USD
CapEx (TTM)663.00M USD
FCF Margin11.62%
FCF Yield3.59%
Net Debt3.53B USD
Net Debt/EBITDA1.48
Net Debt/FCF2.77
Balance Sheet
Debt/Equity0.24
Current Ratio2.50
Quick Ratio1.39
Book Value/Sh37.29 USD
Cash/Share3.76 USD
Dividends
Fwd Div Rate0.33 USD
Trail. Div Rate0.42 USD
Div. Yield0.44%
5Y Avg Yield0.30%
Payout Ratio25.59%
Ex-Div DateMay 5, 2026
Pay DateMay 15, 2025
Analyst Consensus
Rating1.7 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)87.89 USD
Upside (mean)+18.9%
Target Range62.22 USD – 103.81 USD
62.22+18.9% to mean103.81
# Analysts17
Ownership
Shares Out.480.40M
Float479.15M
Insiders0.19%
Institutions66.13%
Technical
SMA 5067.16 (+10.1%)
SMA 20067.93 (+8.8%)
Beta0.72
S&P 52W Chg8.68%
Avg Vol (30d)1.21M
Avg Vol (10d)1.61M
Technical Indicators
RSI (14)61.0
MACD1.6085
MACD Signal1.6048
MACD Hist.+0.0037
BB Upper76.44 USD
BB Middle72.08 USD
BB Lower67.72 USD
BB Width12.10%
ATR (14)1.903 USD
Vol Ratio (20d)1.23x

About Alcon (SWX: ALC)

›

Alcon (SWX: ALC) is listed on the SIX Swiss Exchange, where its shares trade in CHF. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 25,000 employees.

The shares were at 62.28 CHF on 20 November 2026, down 2.3% over 52 weeks. Its 52-week range is 47.80 CHF to 68.34 CHF: the price is 8.9% below the high and 30.3% above the low.

At a market capitalisation of 29.92B CHF, it trades at 57.1 times trailing earnings and 17.3 times forward earnings. The median trailing P/E of its 18 largest Medical Instruments & Supplies peers is 45.0, a premium of 27% for ALC. It pays a dividend yielding 0.44% (it pays out 26% of its earnings), against a median of 1.05% among the dividend payers in that peer group.

Alcon reports return on equity of 4.4%, an operating margin of 12.9% and revenue up 4.7% year over year.

Its debt exceeds its cash by 3.53B USD, a debt-to-equity ratio of 0.24. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 17 analysts cover the stock, with an average rating of Buy; their mean price target of 74.06 CHF is 18.9% above the current price. The next earnings report is expected on 23 February 2027.